Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent development in calcium channel antagonists.

D J Triggle1, R A Janis

  • 1School of Pharmacy, State University of New York, Buffalo.

Magnesium
|January 1, 1989
PubMed
Summary

Calcium channel blockers like verapamil interact with voltage-dependent calcium channels in a state-dependent manner. These interactions explain their antiarrhythmic and vascular effects, highlighting drug selectivity factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overview of chemical diversity.

Current protocols in pharmacology·2011
Same author

Addiction.

IDrugs : the investigational drugs journal·2005
Same author

Division of Medicinal Chemistry--integrins: past, present and future.

IDrugs : the investigational drugs journal·2005
Same author

Interaction of azimilide with neurohumoral and channel receptors.

Biochemical pharmacology·2001
Same author

Regulation of L-type calcium channels in pituitary GH(4)C(1) cells by depolarization.

The Journal of biological chemistry·2001
Same author

Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.

Molecular pharmacology·2000

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Molecular Biology

Background:

  • Clinically available calcium (Ca2+) channel antagonists, such as verapamil, nifedipine, and diltiazem, have significantly impacted cardiovascular medicine.
  • Their introduction spurred extensive research into their mechanisms of action at voltage-dependent Ca2+ channels.

Purpose of the Study:

  • To elucidate the mechanisms of action of Ca2+ channel ligands at voltage-dependent Ca2+ channels.
  • To understand the state-dependent interactions of activators and antagonists with these channels.

Main Methods:

  • Investigated the state-dependent interactions of Ca2+ channel ligands (activators and antagonists).
  • Analyzed frequency- and voltage-dependent interactions of these drugs.
  • Examined factors contributing to drug selectivity.

Main Results:

  • Ca2+ channel ligands exhibit state-dependent interactions, with activators favoring open states and antagonists favoring open and inactivated states.
  • Both frequency- and voltage-dependent interactions were observed for activator and antagonist drugs.
  • Drug selectivity is influenced by Ca2+ demand, stimulus mode, state dependence, ligand character, and Ca2+ channel type.

Conclusions:

  • The state-dependent interaction of Ca2+ channel ligands with voltage-dependent Ca2+ channels is a key mechanism underlying their therapeutic effects.
  • Verapamil's antiarrhythmic activity and the vascular smooth muscle selectivity of 1,4-dihydropyridines are explained by these interactions.
  • Selectivity arises from a complex interplay of system demands, drug properties, and channel characteristics.

Related Experiment Videos